围手术期目标导向液体治疗重度子痫前期的效果观察

摘要

目的：探究重度子痫前期围手术期采用目标导向液体治疗的临床效果。方法：选择笔者所在医院2011年6月-2012年7月间收治的100例重度子痫前期的患者，分为常规治疗的常规组和加入目标导向液体治疗的液体组，各50例。观察两组患者并发症情况和新生儿相关情况、胎儿的Apgar评分情况。结果：液体组患者产生并发症的情况显著于常规组的患者（P<0.05）。液体治疗组患者的新生儿的生长受限例数明显少于常规组（P<0.05）。液体组新生儿重量高于常规组的新生儿（P<0.05）。液体组胎儿Apgar评分大于7分的胎儿显著多于常规组胎儿（P<0.05）。结论：重度子痫前期患者采用目标导向液体治疗可以有效的遏制患者并发症的发生，对胎儿有积极的意义。%　　Objective:To explore against severe preeclampsia perioperative using the goal orientation liquid the clinical effect of treatment. Method:Will be our hospital from June 2011 to July 2012 between 100 cases of severe preeclampsia patients,who were given treatment,divided into conventional treatment of conventional group and join the target orientation of liquid liquid treatment group of two groups of the fifty patients. The two groups were observed and neonatal complications related situation,the fetal Apgar score situation. Result:Liquid groups were significantly superior to the complications arise only with conventional treatment group patients(P<0.05). Liquid treatment group patients with neonatal growth limited number was less than that of conventional treatment group(P<0.05). Liquid group of neonatal weight was higher than pure conventional treatment group newborns (P<0.05). Liquid group Apgar score was more than seven points fetus fetus significantly more than conventional treatment group in the fetus. Conclusion:Severe preeclampsia patients using the goal orientation liquid treatment can effectively patients complications,the fetus has positive significance.